• News
  • SAN DIEGO
  • Finance

Daily Digest

The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.

Acadia Pharmaceuticals Inc.: Company announced it will present at the Cowen and Company 33rd Annual Health Care Conference, March 4 in Boston.

Adventrx Pharmaceuticals Inc.: Company announced it will present at the Cowen and Company 33rd Annual Health Care Conference, March 4 in Boston.

Callaway Golf Company: SEC documents showed Vice President Mark Leposky purchased 14,326 shares at $7.01 per share on Monday.

Cytori Therapeutics Inc.: Company announced it has received a CE Mark in Europe for Intravase.

Jack In The Box Inc.: SEC documents showed Officer Gary Beisler exercised options on 50,000 shares at $24.74 to $26.28 per share, and sold 50,000 shares at $31.70 to $31.83 per share on Friday.

Ligand Pharmaceuticals-Cl B: Company announced it received a $1.4 million milestone payment from Retrophin Inc., as part of a licensing agreement signed in February 2012 for the development and commercialization of Retrophinís lead clinical candidate, RE-021.

Lpath Inc.-Class A: Company announced it will present at Arrowheadís Third Annual Traumatic Brain Injury Conference.

Quidel Corp.: Company announced it will host its 2013 Quidel Analyst and Investor Day in Boston, March 7.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!